[{"id":"0c9c74d6-485b-4485-94f9-eb7a56d84916","acronym":"","url":"https://clinicaltrials.gov/study/NCT06549634","created_at":"2025-02-25T16:48:12.139Z","updated_at":"2025-02-25T16:48:12.139Z","phase":"","brief_title":"Biomarkers of AKI in Patients Receiving Daratumumab","source_id_and_acronym":"NCT06549634","lead_sponsor":"Brigham and Women's Hospital","biomarkers":" DKK3","pipe":"","alterations":" ","tags":["DKK3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Darzalex (daratumumab)"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 09/01/2024","start_date":" 09/01/2024","primary_txt":" Primary completion: 09/01/2026","primary_completion_date":" 09/01/2026","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2025-02-05"},{"id":"51936778-255b-400c-b37a-da7727ddb09d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01931046","created_at":"2021-04-25T09:40:57.081Z","updated_at":"2024-07-02T16:36:41.343Z","phase":"Phase 1/2","brief_title":"Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer","source_id_and_acronym":"NCT01931046","lead_sponsor":"Momotaro-Gene Inc.","biomarkers":" DKK3","pipe":"","alterations":" ","tags":["DKK3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ad-SGE-REIC"],"overall_status":"Completed","enrollment":" Enrollment 28","initiation":"Initiation: 10/01/2013","start_date":" 10/01/2013","primary_txt":" Primary completion: 07/06/2018","primary_completion_date":" 07/06/2018","study_txt":" Completion: 03/01/2020","study_completion_date":" 03/01/2020","last_update_posted":"2020-09-04"}]